VHOSPITAL.CLINIC · Differential Diagnosis
Cardiomyopathy vs Heart Failure
Clinical comparison — shared symptoms, key differences, distinguishing diagnostic tests, treatment pathways, and when to seek urgent evaluation.
Condition Overview
Condition A
Cardiomyopathy
Cardiomyopathy is disease of the heart muscle that impairs its ability to pump blood effectively. Types include dilated (most common), hypertrophic, and restrictive; causes range from genetic mutations to chronic alcohol use.
Condition B
Heart Failure
Heart failure occurs when the heart cannot pump enough blood to meet the body's needs. It is a chronic condition that causes fatigue, shortness of breath, and fluid retention (edema). It requires ongoing medical management.
Shared Symptoms — Why They're Confused
Both conditions present with 5 overlapping symptoms, making clinical differentiation essential.
Key Clinical Differences
Cardiomyopathy
- Primary disease of heart muscle (dilated, hypertrophic, restrictive)
- May be genetic, viral, toxic (alcohol), or idiopathic
- Diagnosis requires echocardiographic structural abnormality
- Can cause heart failure but is the underlying aetiology
Heart Failure
- Clinical syndrome of dyspnoea, oedema, reduced exercise tolerance
- End-result of many conditions including cardiomyopathy, IHD, hypertension
- Diagnosed by symptoms + BNP elevation + imaging
- BNP/NT-proBNP elevated as marker of ventricular stress
Distinguishing Diagnostic Tests
| Test | Cardiomyopathy | Heart Failure |
|---|---|---|
| Echocardiography | Dilated LV with reduced EF, or hypertrophied walls (HCM), or restrictive filling | May show dilated LV with reduced EF; identifies the cause |
| Cardiac MRI | Late gadolinium enhancement pattern identifies myocardial fibrosis/scar | Used to characterise underlying aetiology |
| Genetic testing | Positive in familial cardiomyopathies (TTN, LMNA, MYH7 mutations) | Not routinely performed for heart failure workup |
Treatment Approaches
Cardiomyopathy
- •Treat underlying cause (abstinence from alcohol, antiviral for viral CM)
- •ACE inhibitor + beta-blocker + MRA
- •ICD for sudden death prevention
- •Cardiac transplant in end-stage
Heart Failure
- •ACE inhibitor/ARB + beta-blocker + loop diuretic + MRA
- •SGLT2 inhibitor (HFrEF)
- •Device therapy: CRT, ICD
- •Sodium/fluid restriction
When Doctors Consider Each Diagnosis
🔵 Consider Cardiomyopathy when:
- →Structural myocardial disease on echo without a clear ischaemic cause
- →Young patient with family history
🟢 Consider Heart Failure when:
- →Clinical syndrome with elevated BNP and volume overload
- →Known precipitant (ischaemia, hypertension, valve disease)
Explore Each Condition in Detail
Related Clinical Pages
Cardiomyopathy
Medical References
Content on this page is informed by evidence-based clinical sources including:
- World Health Organization (WHO)Global health guidance and disease classification
- National Health Service (NHS)UK clinical guidelines and patient information
- National Institute for Health and Care Excellence (NICE)Evidence-based clinical practice guidelines
- Centers for Disease Control and Prevention (CDC)US public health data and clinical recommendations
- PubMed – NCBIPeer-reviewed biomedical literature and clinical studies
- Cochrane LibrarySystematic reviews and meta-analyses in evidence-based medicine
Not sure which condition applies to you?
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →